Location: Home
  • search
  • go
  • Relate News
  • 4/29/2025Innovent Announces NMPA Approval of Limertinib
  • 4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...
  • 4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...
  • 4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...
  • 4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
  • 4/29/202553 Original Research Drugs Approved in China in Early 2025
  • 4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...
  • 4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements
  • 4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...
  • 4/29/2025High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Cris...
  • 4/26/2025China Aims for Significant Pharma Industry Digital Transformation by 2...
  • 4/26/2025Recent Executive Moves
  • 4/25/2025JIBP Aims for Hong Kong IPO amid Biopharma Market Revival
  • 4/25/2025AstraZeneca China Announces Major Reorganization to Bolster Biopharma ...
  • 4/25/2025China's Fast-Track Drug Approvals Accelerating Access to Novel Therapi...
  • 4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
  • 4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
  • 4/25/2025Akeso's Ivonescimab Gains Second Approval in China
  • 4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
  • 4/25/2025China's Innovative Drug Licensing Deals Soar, Big Pharma Leads the Buy...
  • 4/25/2025Cell Therapy to AI: How J&J Has Been Sourcing the Transformational Sci...
  • 4/25/2025MNC Pharma's Q1/2025 China Performance: Divergent Fortunes Amid Pricin...
  • 4/24/2025US Capital Crunch Pushes China Biotechs to Roundabout Financings (Phar...
  • 4/24/2025China Biopharma Tracker – March 2025 (PharmaDJ)
  • 4/24/2025Ascletis Challenges Lilly, Novo With Promising Oral GLP-1 Data
  • 4/24/2025Bayer Pharma Accelerates Growth in China with Breakthru Therapies and ...
  • 4/24/2025Merck's Gardasil Sales Plunge Amid China Market Turbulence
  • 4/24/2025LTZ Thera Secures $40M in Oversubscribed Series A+ to Advance FIC Im...
  • 4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
  • 4/23/2025China Accelerates Development of Multivalent Vaccines and Digital Immu...
  • Page:40/802 Total number of articles:24041: [First][<<] [38] [39] [40] [41] [42] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group